
Ali Bauerlein
Ms. Bauerlein is an experienced entrepreneur and finance executive with a strong background in the durable medical equipment industry. She co-founded Inogen (Nasdaq: INGN) in 2001 to improve freedom and independence for oxygen therapy patients worldwide, and previously served as Inogen’s Chief Financial Officer, Corporate Secretary, and Corporate Treasurer with responsibilities for all areas of finance, accounting, reporting, investor relations, treasury, SOX compliance, legal, and revenue management. In addition to serving on the board of directors of Equinox Ophthalmic, Ms. Bauerlein serves on the board of directors of Koya Medical, a lymphatic and venous care medical device company, Pear Therapeutics (NASDAQ: PEAR), a prescription digital therapeutics company, and Gelesis Holdings, Inc, (NYSE: GLS), a biotherapeutics company. She received her B.A. in Economics/Mathematics from the University of California, Santa Barbara.